Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vijay Kumar Prajapati

Showing results (1-10 of 127) with videos related to

Pageof 13
Sort By:
Progress in Molecular Biology and Translational Science|September 22, 2025
PrefaceVijay Kumar Prajapati
Advances in Protein Chemistry and Structural Biology|February 20, 2025
PrefaceDr Vijay Kumar Prajapati
Current Medicinal Chemistry|May 23, 2012
Drug targeting to infectious diseases by nanoparticles surface functionalized with special biomoleculesShyam Sundar, Vijay Kumar Prajapati
Journal of Cellular Physiology|June 25, 2021
Cognizance of posttranslational modifications in vaccines: A way to enhanced immunogenicityRupal Ojha, Vijay Kumar Prajapati
3 Biotech|August 24, 2022
Exploring actinomycetes natural products to identify potential multi-target inhibitors against <i>Leishmania donovani</i>Satyendra Singh, Vijay Kumar Prajapati
International Journal of Biological Macromolecules|October 12, 2017
Molecular and immunological toxic effects of nanoparticlesRajan Kumar Pandey, Vijay Kumar Prajapati
Journal of Cellular Biochemistry|January 30, 2018
Exploring sand fly salivary proteins to design multiepitope subunit vaccine to fight against visceral leishmaniasisRajan Kumar Pandey, Vijay Kumar Prajapati
Advances in Protein Chemistry and Structural Biology|February 20, 2025
From infection to remedy: Harnessing oncolytic viruses in cancer treatmentSramona Kar, Sanjana Mehrotra, Vijay Kumar Prajapati
Journal of Cellular Physiology|October 27, 2018
Contriving multiepitope subunit vaccine by exploiting structural and nonstructural viral proteins to prevent Epstein-Barr virus-associated malignancyRupal Ojha, Raj Nandani, Vijay Kumar Prajapati
Advances in Protein Chemistry and Structural Biology|February 20, 2025
Exploring immunotherapy to control human infectious diseasesPraveen Rai, Sanjana Mehrotra, Vijay Kumar Prajapati
Pageof 13

Showing results (1-10 of 127) with videos related to

Sort By:
Pageof 13
Progress in Molecular Biology and Translational Science|September 22, 2025
PrefaceVijay Kumar Prajapati
Advances in Protein Chemistry and Structural Biology|February 20, 2025
PrefaceDr Vijay Kumar Prajapati
Current Medicinal Chemistry|May 23, 2012
Drug targeting to infectious diseases by nanoparticles surface functionalized with special biomoleculesShyam Sundar, Vijay Kumar Prajapati
Journal of Cellular Physiology|June 25, 2021
Cognizance of posttranslational modifications in vaccines: A way to enhanced immunogenicityRupal Ojha, Vijay Kumar Prajapati
3 Biotech|August 24, 2022
Exploring actinomycetes natural products to identify potential multi-target inhibitors against <i>Leishmania donovani</i>Satyendra Singh, Vijay Kumar Prajapati
International Journal of Biological Macromolecules|October 12, 2017
Molecular and immunological toxic effects of nanoparticlesRajan Kumar Pandey, Vijay Kumar Prajapati
Journal of Cellular Biochemistry|January 30, 2018
Exploring sand fly salivary proteins to design multiepitope subunit vaccine to fight against visceral leishmaniasisRajan Kumar Pandey, Vijay Kumar Prajapati
Advances in Protein Chemistry and Structural Biology|February 20, 2025
From infection to remedy: Harnessing oncolytic viruses in cancer treatmentSramona Kar, Sanjana Mehrotra, Vijay Kumar Prajapati
Journal of Cellular Physiology|October 27, 2018
Contriving multiepitope subunit vaccine by exploiting structural and nonstructural viral proteins to prevent Epstein-Barr virus-associated malignancyRupal Ojha, Raj Nandani, Vijay Kumar Prajapati
Advances in Protein Chemistry and Structural Biology|February 20, 2025
Exploring immunotherapy to control human infectious diseasesPraveen Rai, Sanjana Mehrotra, Vijay Kumar Prajapati
Pageof 13